Related Experiment Video
Updated: Feb 2, 2026
10:04
A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes
Published on: March 3, 2018
7.1K
Nonlinear System Identification Based on Convolutional Neural Networks for Multiple Drug Interactions.
Summary
Convolutional neural networks (CNNs) accurately predict complex cardiovascular drug responses in heart failure. This advanced technique aids in understanding pharmacodynamics for better patient treatment.
Area of Science:
- Biomedical Engineering
- Pharmacology
- Computational Biology
Background:
- Hemodynamic regulation in heart failure patients involves complex cardiovascular responses to therapeutic drugs.
- Nonlinearity and drug interactions complicate the accurate identification of drug dynamics.
Purpose of the Study:
- To evaluate convolutional neural networks (CNNs) for nonlinear system identification of cardiovascular drug responses.
- To compare CNNs against traditional methods like standard neural networks (NN) and fast Fourier transformation (FFT).
Main Methods:
- CNNs were employed to model the relationship between drug infusions (inputs) and hemodynamic outputs (cardiac output, arterial blood pressure).
- Drug interactions were simulated using an inotropic agent and a vasodilator in a heart failure model.
- Performance was compared with NN and FFT for nonlinear system identification.
Main Results:
- CNNs demonstrated high accuracy in predicting dynamic system responses, even with inherent nonlinearity and drug interactions.
- CNNs effectively captured the complicated relationships between drug inputs and hemodynamic outputs.
Conclusions:
- CNNs offer a powerful tool for nonlinear system identification in complex pharmacological scenarios.
- This approach can clarify intricate pharmacodynamics, supporting optimized cardiac treatment strategies involving multiple agents.
Related Concept Videos
02:26Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
159
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
159
01:17Convolution Properties II
587
The important convolution properties include width, area, differentiation, and integration properties.
The width property indicates that if the durations of input signals are T1 and T2, then the width of the output response equals the sum of both durations, irrespective of the shapes of the two functions. For instance, convolving two rectangular pulses with durations of 2 seconds and 1 second results in a function with a width of 3 seconds.
The area property asserts that the area under the...
The width property indicates that if the durations of input signals are T1 and T2, then the width of the output response equals the sum of both durations, irrespective of the shapes of the two functions. For instance, convolving two rectangular pulses with durations of 2 seconds and 1 second results in a function with a width of 3 seconds.
The area property asserts that the area under the...
587
01:22Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
622
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
622
01:22Nonlinear Pharmacokinetics: Causes of Nonlinearity
735
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
735
01:25Pharmacokinetics: Drug–Drug Interactions
442
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
442